Relacatib (SB-462795) is a novel, potent, and orally active inhibitor of human cathepsins K, L, and V with Ki values of 41 pM, 68 pM, and 53 pM, respectively. Relacatib inhibits endogenous cathepsin K in situ in human osteoclasts and human osteoclast-mediated bone resorption with IC50 values of 45 nM and 70 nM, respectively. Relacatib inhibits bone resorption in vitro in human tissue as well as in cynomolgus monkeys in vivo[1][2].
Molecular Weight:
540.63
Purity:
99.99
CAS Number:
[362505-84-8]
Formula:
C27H32N4O6S
Target:
Cathepsin
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted